Contraception
Volume 82, Issue 1 , Pages 38-40 , July 2010

Intrauterine device use among women with ovarian cancer: a systematic review

Received 4 February 2010 ,Accepted 4 February 2010.

References 

  1. American Cancer Society. Ovarian cancer. Atlanta (Ga): American Cancer Society. Accessed November 12, 2008 http://documents.cancer.org/114.00/114.00.pdf2008;
  2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA: A Cancer J Clin. 2008;58:71–96
  3. Horner M, Ries L, Krapcho M, et al. SEER cancer statistics review, 1975–2006. Bethesda (Md): National Cancer Institute. Accessed September 25, 2009 http://seer.cancer.gov/csr/1975_2006/results_merged/sect_21_ovary.pdf2009;
  4. Chen VW, Ruiz B, Killeen JL, Cote TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer. 2003;97:2631–2642
  5. Chen L, Berek JS. Epithelial ovarian cancer: clinical manifestations, diagnostic evaluation, staging, and histopathology. In:  Basow DS editors. UpToDate. Waltham (Mass): UpToDate; 2008;
  6. Chen LM, Berek JS. Ovarian tumors of low malignant potential. In:  Basow DS editors. UpToDate. Waltham (Mass): UpToDate; 2008;
  7. Eltabbakh GH, Natarajan N, Piver S, Mettlin CJ. Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. Gynecol Oncol. 1999;74:103–107
  8. Bast RC, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009;9:415–428
  9. Dorigo O, Berek JS. Sex cord-stromal tumors of the ovary. In:  Basow DS editors. UpToDate. Waltham (Mass): UpToDate; 2008;
  10. Goodman MT, Correa CN, Tung K, et al. Stage at diagnosis of ovarian cancer in the United States, 1992–1997. Cancer. 2003;97:2648–2659
  11. Ries L, Melbert D, Krapcho M, et al. SEER cancer statistics review, 1975–2005. Bethesda (Md): National Cancer Institute. Accessed November 12, 2008 http://seer.cancer.gov/csr/1975_20052008;
  12. Mann WJ, Chalas E, Valea FA. Initial surgical management of epithelial ovarian cancer. In:  Basow DS editors. UpToDate. Waltham (Mass): UpToDate; 2008;
  13. Browne H, Manipalviratn S, Armstrong A. Using an intrauterine device in immunocompromised women. Obstet Gynecol. 2008;112:667–669
  14. World Health Organization . Medical eligibility criteria for contraceptive use. 3rd ed.. Geneva: World Health Organization; 2004;
  15. World Health Organization . Medical eligibility criteria for contraceptive use, 2008 update. Geneva: World Health Organization. Accessed July 9, 2009 http://whqlibdoc.who.int/hq/2008/WHO_RHR_08.19_eng.pdf2009;

☆ Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

PII: S0010-7824(10)00057-0

doi: 10.1016/j.contraception.2010.02.013

Contraception
Volume 82, Issue 1 , Pages 38-40 , July 2010

Article Tools